EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Drug Utilization and Evaluation Of Paclitaxel In Patients With Ovarian,Cervical And Breast Cancer

Kevin jeyaraj S, Likhitha G K, Pavithra Infancia P J, Nandini M S, Vishveshwara M S, Hanumanthachar Joshi

International Journal of Community Pharmacy · 30.03.2023 · 21-25

DOI: 10.65301/ijcp.2023.1.4.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Community Pharmacy, online erschienen am 30.03.2023. Verfasst von Kevin jeyaraj S und 5 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Cancer is growing into a leading health and economic crisis worldwide causing over 10 million deaths in 2020. AIMS AND OBJECTIVES: Assessment of treatment effectiveness of paclitaxel.(Primary objective) Assessing the drug utilization of paclitaxel in ovary, breast and cervical cancer. To determine the correlation between menarche and menopause with occurrence of cancer in women. To review and analyze these verity of drug associated ADRs METHODS: Various methods were used to find out the objective of the study. RESULTS: Out of 68 patients, 41 patients were having breast cancer, 22 patients with ovary cancer and 5 patients with cervical cancer. CONCLUSION: Our study found that majority of the study population that is about 60% were affected by breast cancer, followed by 32% of population with the diagnosis of ovarian cancer and 7% with cervical cancer. The correlation of age at menarche and incidence of cancer in women showed the greater incidence of ovarian and breast cancer in women with early menarche. The ADR was analysed using naranjo’s scale and CTCAE grading scale and most of them experienced drug induced burning or tingling sensation, peripheral neuropathy, myalgia and hypersensitivity reaction during the chemotherapy administration.

Zitieren

APA

S, K. J., K, L. G., J, P. I. P., S, N. M., S, V. M., & Joshi, H. (2023). Drug Utilization and Evaluation Of Paclitaxel In Patients With Ovarian,Cervical And Breast Cancer. International Journal of Community Pharmacy, 21-25. https://doi.org/10.65301/ijcp.2023.1.4.2

Vancouver

S KJ, K LG, J PIP, S NM, S VM, Joshi H. Drug Utilization and Evaluation Of Paclitaxel In Patients With Ovarian,Cervical And Breast Cancer. International Journal of Community Pharmacy. 2023:21-25. doi:10.65301/ijcp.2023.1.4.2

BibTeX
@article{S2023,
  author = {S, Kevin jeyaraj and K, Likhitha G and J, Pavithra Infancia P and S, Nandini M and S, Vishveshwara M and Joshi, Hanumanthachar},
  title = {Drug Utilization and Evaluation Of Paclitaxel In Patients With Ovarian,Cervical And Breast Cancer},
  journal = {International Journal of Community Pharmacy},
  year = {2023},
  pages = {21--25},
  doi = {10.65301/ijcp.2023.1.4.2}
}
Kostenlos starten →